GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital solutions provider. Its products, services, and solutions enable clinicians to make informed decisions, improving patient care from diagnosis to the…
Medical - Healthcare Information Services
US, Chicago [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 24.82 | 60.08 | 48.13 | |
| Graham Fair Price | -2.04 | 17.31 | 17.68 | |
| PEG | 35.72 | -3.47 | 2.56 | |
| Price/Book | 11.74 | 5.51 | 4.93 | |
| Price/Cash Flow | 304.89 | 149.00 | 36.80 | |
| Prices/Earnings | 25.04 | 27.29 | 21.82 | |
| Price/Sales | 29.92 | 8.78 | 6.76 | |
| Price/FCF | 304.89 | 149.00 | 36.80 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -1.28 | 0.41 | 0.41 | |
| Operating Margin | -12.25 | 0.12 | 0.13 | |
| ROA | -6.49 | 0.01 | 0.01 | |
| ROE | 0.06 | 0.05 | -10.64 | |
| ROIC | 0.03 | 0.02 | -13.46 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.02 | -0.04 | 48.90 | |
| Dividends QOQ | -0.07 | 0.07 | 4.39 | |
| EBIT QOQ | 0.12 | -0.22 | 85.32 | |
| EPS QOQ | 0.09 | -0.08 | -7.87 | |
| FCF QOQ | 0.68 | -0.71 | 5.35 | |
| Revenue QOQ | 0.08 | -0.11 | 34.11 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 57.84 | 65.12 | 12.59 | |
| Days Sales Outstanding (DSO) | 73.54 | 77.75 | 5.72 | |
| Inventory Turnover | 1.56 | 1.38 | -11.18 | |
| Debt/Capitalization | 0.58 | 0.57 | -2.44 | |
| Quick Ratio | 0.75 | 0.74 | -1.33 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 15.68 | 16.25 | 3.63 | |
| Cash | 5.48 | 5.59 | 2.06 | |
| Capex | -0.21 | -0.32 | -53.92 | |
| Free Cash Flow | 2.10 | 0.60 | -71.40 | |
| Revenue | 11.44 | 10.20 | -10.88 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad